Search research articles
Contact Us
Filters
Showing results (81-90 of 159) with videos related to
Page
of 16
Sort By:
Plos One
|
February 25, 2009
A novel immunological assay for hepcidin quantification in human serum
Vasiliki Koliaraki, Martha Marinou, Theodoros P Vassilakopoulos, et al.
Clinical Transplantation
|
May 13, 2017
An objective definition for clinical suspicion of T-cell-mediated rejection after liver transplantation
Manuel Rodríguez-Perálvarez, Laura De Luca, Gonzalo Crespo, et al.
The Cochrane Database of Systematic Reviews
|
April 4, 2017
Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis
Elena Buzzetti, Maria Kalafateli, Douglas Thorburn, et al.
The American Journal of Gastroenterology
|
January 16, 2007
Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors
Emmanuel Tsochatzis, George V Papatheodoridis, Emanuel K Manesis, et al.
Hepatology (Baltimore, Md.)
|
February 14, 2020
New Drugs for NASH and HIV Infection: Great Expectations for a Great Need
Giovanni Guaraldi, James B Maurice, Catia Marzolini, et al.
Journal of Hepatology
|
October 2, 2012
Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome
Manuel Rodríguez-Perálvarez, Giacomo Germani, Vasilios Papastergiou, et al.
Journal of Hepatology
|
November 9, 2010
Assessment of adrenocortical reserve in stable patients with cirrhosis
Giuseppe Fede, Luisa Spadaro, Tania Tomaselli, et al.
Theranostics
|
January 7, 2020
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> regulatory T cells activation
Oriana Lo Re, Tommaso Mazza, Sebastiano Giallongo, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 22, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018
Alice Morgan, Sally Hartmanis, Emmanuel Tsochatzis, et al.
Hepatology (Baltimore, Md.)
|
July 12, 2017
Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease
Salvador Augustin, Mònica Pons, James B Maurice, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 159) with videos related to
Sort By:
Page
of 16
Plos One
|
February 25, 2009
A novel immunological assay for hepcidin quantification in human serum
Vasiliki Koliaraki, Martha Marinou, Theodoros P Vassilakopoulos, et al.
Clinical Transplantation
|
May 13, 2017
An objective definition for clinical suspicion of T-cell-mediated rejection after liver transplantation
Manuel Rodríguez-Perálvarez, Laura De Luca, Gonzalo Crespo, et al.
The Cochrane Database of Systematic Reviews
|
April 4, 2017
Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis
Elena Buzzetti, Maria Kalafateli, Douglas Thorburn, et al.
The American Journal of Gastroenterology
|
January 16, 2007
Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors
Emmanuel Tsochatzis, George V Papatheodoridis, Emanuel K Manesis, et al.
Hepatology (Baltimore, Md.)
|
February 14, 2020
New Drugs for NASH and HIV Infection: Great Expectations for a Great Need
Giovanni Guaraldi, James B Maurice, Catia Marzolini, et al.
Journal of Hepatology
|
October 2, 2012
Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome
Manuel Rodríguez-Perálvarez, Giacomo Germani, Vasilios Papastergiou, et al.
Journal of Hepatology
|
November 9, 2010
Assessment of adrenocortical reserve in stable patients with cirrhosis
Giuseppe Fede, Luisa Spadaro, Tania Tomaselli, et al.
Theranostics
|
January 7, 2020
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> regulatory T cells activation
Oriana Lo Re, Tommaso Mazza, Sebastiano Giallongo, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 22, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018
Alice Morgan, Sally Hartmanis, Emmanuel Tsochatzis, et al.
Hepatology (Baltimore, Md.)
|
July 12, 2017
Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease
Salvador Augustin, Mònica Pons, James B Maurice, et al.
Page
of 16